Mohammed A - Search Results

1

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.

Kapetanovic IM, Muzzio M, McCormick DL, Thompson TN, Johnson WD, Horn TL, Mohammed A, Rao CV, Kopelovich L. Kapetanovic IM, et al. Among authors: mohammed a. Cancer Chemother Pharmacol. 2012 May;69(5):1301-6. doi: 10.1007/s00280-011-1811-9. Cancer Chemother Pharmacol. 2012. PMID: 22302406

2

Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells.

Janakiram NB, Cooma I, Mohammed A, Steele VE, Rao CV. Janakiram NB, et al. Among authors: mohammed a. Mol Cancer Ther. 2008 Jan;7(1):181-90. doi: 10.1158/1535-7163.MCT-07-0529. Mol Cancer Ther. 2008. PMID: 18202021

3

Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids.

Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, Rao CV. Swamy MV, et al. Among authors: mohammed a. Nutr Cancer. 2008;60 Suppl 1:81-9. doi: 10.1080/01635580802416703. Nutr Cancer. 2008. PMID: 19003584

4

Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growth.

Janakiram NB, Mohammed A, Zhang Y, Choi CI, Woodward C, Collin P, Steele VE, Rao CV. Janakiram NB, et al. Among authors: mohammed a. Cancer Prev Res (Phila). 2010 Jan;3(1):82-91. doi: 10.1158/1940-6207.CAPR-09-0112. Cancer Prev Res (Phila). 2010. PMID: 20051375

5

The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.

Mohammed A, Janakiram NB, Li Q, Madka V, Ely M, Lightfoot S, Crawford H, Steele VE, Rao CV. Mohammed A, et al. Cancer Prev Res (Phila). 2010 Nov;3(11):1417-26. doi: 10.1158/1940-6207.CAPR-10-0038. Cancer Prev Res (Phila). 2010. PMID: 21084261 Free PMC article.

6

Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.

Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE, Rao CV. Mohammed A, et al. Cancer Prev Res (Phila). 2011 Dec;4(12):2015-26. doi: 10.1158/1940-6207.CAPR-11-0233. Epub 2011 Sep 1. Cancer Prev Res (Phila). 2011. PMID: 21885812 Free PMC article.

7

Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer.

Janakiram NB, Mohammed A, Rao CV. Janakiram NB, et al. Among authors: mohammed a. Cancer Metastasis Rev. 2011 Dec;30(3-4):507-23. doi: 10.1007/s10555-011-9311-2. Cancer Metastasis Rev. 2011. PMID: 22015691 Review.

8

Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice.

Mohammed A, Qian L, Janakiram NB, Lightfoot S, Steele VE, Rao CV. Mohammed A, et al. Int J Cancer. 2012 Oct 15;131(8):1951-62. doi: 10.1002/ijc.27456. Epub 2012 Mar 14. Int J Cancer. 2012. PMID: 22287227 Free PMC article.

9

Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.

Janakiram NB, Mohammed A, Qian L, Choi CI, Steele VE, Rao CV. Janakiram NB, et al. Among authors: mohammed a. Neoplasia. 2012 Feb;14(2):159-68. doi: 10.1593/neo.111440. Neoplasia. 2012. PMID: 22431924 Free PMC article.

10

Prophylactic vaccine approach for colon and pancreatic cancers: present and future.

Janakiram NB, Mohammed A, Bronze MS, Rao CV. Janakiram NB, et al. Among authors: mohammed a. Curr Med Chem. 2012;19(22):3664-78. doi: 10.2174/092986712801661022. Curr Med Chem. 2012. PMID: 22680926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,395 results

Search Page

Filters